Identification of men with the highest risk of early disease recurrence after radical prostatectomy

被引:19
|
作者
Sundi, Debasish [1 ]
Wang, Vinson [1 ]
Pierorazio, Phillip M. [1 ]
Han, Misop [1 ]
Partin, Alan W. [1 ]
Tran, Phuoc T. [1 ]
Ross, Ashley E. [1 ]
Bivalacqua, Trinity J. [1 ]
机构
[1] Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA
来源
PROSTATE | 2014年 / 74卷 / 06期
关键词
intraoperative therapy; early biochemical recurrence; prostate cancer; multimodal therapy; RANDOMIZED CLINICAL-TRIAL; LYMPH-NODE DISSECTION; ADJUVANT RADIOTHERAPY; INTRAOPERATIVE RADIOTHERAPY; POSTOPERATIVE RADIOTHERAPY; RADIATION-THERAPY; CANCER; METASTASES;
D O I
10.1002/pros.22780
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Men destined to have early biochemical recurrence (BCR) following radical prostatectomy (RP) may be optimal candidates for multimodal treatment. Here we identified pre-operative predictors of early BCR within a surgical cohort who recurred. METHODS An institutional prostate cancer (PCa) database containing over 20,000 patients was queried to identify 1,471 men who had BCR after RP, and pre-operative predictors of early versus late BCR were assessed. Early BCR was defined as recurrence within 1 year after RP. Within the recurrence cohort, those with National Comprehensive Cancer Network (NCCN) high-risk features were more likely to experience early BCR. Therefore, in all NCCN high-risk men in the database, we abstracted detailed pathologic biopsy data. Among 753 high-risk men, 41 alternate multivariable criteria were assessed for their ability to predict early BCR in crude and adjusted logistic regression models. RESULTS The criteria that best identified those likely to experience early BCR are primary Gleason pattern 5 on biopsy or >= 4 cores containing pattern 4 (odds ratio 3.17, P < 0.001). These criteria included 26.7% of NCCN high-risk men. Additionally, these criteria selected for men within the high-risk classification who were at significantly higher risk of subsequent metastasis (adjusted hazard ratio 3.04, P < 0.001) and cancer-specific death (adjusted hazard ratio 3.27, P < 0.001). CONCLUSIONS In men with PCa who present with high-risk features, pre-operative criteria have the ability to discriminate the subgroup most likely to experience early BCR after RP. Men at risk for early disease recurrence may be the most suitable candidates for multimodal therapy. Prostate 74:628-636, 2014. (c) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:628 / 636
页数:9
相关论文
共 50 条
  • [41] Significant Change in Predicted Risk of Biochemical Recurrence After Radical Prostatectomy More Common in Black Than in White Men
    Laudano, Melissa A.
    Badani, Ketan K.
    McCann, Tara R.
    Mann, Mark J.
    Ritch, Chad
    Desai, Manisha
    Benson, Mitchell C.
    McKiernan, James M.
    UROLOGY, 2009, 74 (03) : 660 - 664
  • [42] Defining biochemical recurrence after radical prostatectomy and timing of early salvage radiotherapy
    Budaeus, Lars
    Schiffmann, Jonas
    Graefen, Markus
    Huland, Hartwig
    Tennstedt, Pierre
    Siegmann, Alessandra
    Boehmer, Dirk
    Budach, Volker
    Bartkowiak, Detlef
    Wiegel, Thomas
    STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 (09) : 692 - 699
  • [43] Nomogram Predicting the Probability of Early Recurrence After Radical Prostatectomy for Prostate Cancer
    Walz, Jochen
    Chun, Felix K. -H.
    Klein, Eric A.
    Reuther, Alwyn
    Saad, Fred
    Graefen, Markus
    Huland, Hartwig
    Karakiewicz, Pierre I.
    JOURNAL OF UROLOGY, 2009, 181 (02): : 601 - 607
  • [44] Radiotherapy for PSA recurrence after radical prostatectomy
    Vanuytsel, L
    Janssens, G
    Van Poppel, H
    Rijnders, A
    Baert, L
    EUROPEAN UROLOGY, 2001, 39 (04) : 425 - 429
  • [45] Diagnosis of local recurrence after radical prostatectomy
    Scattoni, V
    Montorsi, F
    Picchio, M
    Roscigno, M
    Salonia, A
    Rigatti, P
    Fazio, F
    BJU INTERNATIONAL, 2004, 93 (05) : 680 - 688
  • [46] Characterization of biochemical recurrence after radical prostatectomy
    Molitierno, Joseph
    Evans, Aubrey
    Mohler, James L.
    Wallen, Eric
    Moore, Dominic
    Pruthi, Raj S.
    UROLOGIA INTERNATIONALIS, 2006, 77 (02) : 130 - 134
  • [47] Radiotherapy in PSA recurrence after radical prostatectomy
    Neu, B
    Hütenschmidt, B
    Sautter-Bihl, ML
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 : 5 - 5
  • [48] Influence of node-positive disease after radical prostatectomy on biochemical recurrence and oncologic outcomes in men with prostate cancer
    Washington, Samuel L.
    Cowan, Janet E.
    Herlemann, Annika
    Zuniga, Kyle Brian
    Carroll, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [49] ULTRASENSITIVE PSA SURVEILLANCE AFTER RADICAL PROSTATECTOMY BASED ON RECURRENCE RISK STRATIFICATION
    Mak, D. K. C.
    Boddy, J. L.
    Vishal, V. R.
    Luscombe, C.
    Doherty, A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 237 - 237
  • [50] Biostatistical modeling using traditional preoperative and pathological prognostic variables in the selection of men at high risk for disease recurrence after radical prostatectomy for prostate cancer
    Bauer, JJ
    Connelly, RR
    Seterhenn, IA
    Deausen, J
    Srivastava, S
    McLeod, DG
    Moul, JW
    JOURNAL OF UROLOGY, 1998, 159 (03): : 929 - 933